Back to results
US 2016/0354320 A1Published application
Drug loaded polymeric nanoparticles and methods of making and using same
AssigneeBIND Therapeutics, Inc.
InventorStephen E. Zale
Life of this patent
Estimating the term…
Abstract
The present disclosure generally relates to nanoparticles having about 0.2 to about 35 weight percent of a therapeutic agent; and about 10 to about 99 weight percent of biocompatible polymer such as a diblock poly(lactic) acid-poly(ethylene)glycol. Other aspects of the invention include methods of making such nanoparticles.
Claims27
A therapeutic nanoparticle comprising:
- about 0.2 to about 35 weight percent of a therapeutic agent;
- about 10 to about 99 weight percent of a diblock poly(lactic) acid-poly(ethylene)glycol copolymer or a diblock poly(lactic)-co-poly (glycolic) acid-poly(ethylene)glycol copolymer;
- and
- about 0 to about 75 weight percent poly(lactic) acid or poly(lactic) acid-co-poly (glycolic) acid.
1 more element
(canceled)
(canceled)
(canceled)
(canceled)
15-18. (canceled)
25-34. (canceled)
(canceled)
A pharmaceutical composition comprising:
- a plurality of polymeric nanoparticles each comprising about 0.2 to about 35 weight percent of a therapeutic agent, about 70 to about 99 weight percent of a biocompatible polymer, and optionally a fatty alcohol;
- wherein the biocompatible polymer is selected from the group consisting of:
- a) poly(lactic) acid-poly(ethylene)glycol copolymer;
- b) poly(lactic)-co-poly (glycolic) acid-poly(ethylene)glycol copolymer;
- c) a combination of a) or b) and poly (lactic) acid or polylactic-co-glycolic acid copolymer;
- and
- a pharmaceutically acceptable excipient.
4 more elements
39-47. (canceled)
Dependencies are inferred from the claim text.